Prevalence of Hepatitis A Virus Antibody in Portuguese Travelers: A New Paradigm.

Authors:
Sonia Rocha
Sonia Rocha
College of Life Sciences
Provo | United States
Sandra Tejo
Sandra Tejo
Serviço de Doenças Infeciosas. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal
Coimbra | Portugal
Eugenia Ferreira
Eugenia Ferreira
Laboratory of Antimicrobial Resistance
Nuno Marques
Nuno Marques
Centro Hospitalar e Universitário de Coimbra
Coimbra | Portugal

Acta Med Port 2017 Aug 31;30(7-8):534-540. Epub 2017 Aug 31.

Serviço de Doenças Infeciosas. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.

Introduction: In Portugal, the prevalence of hepatitis A virus infection has decreased in the past decades, especially in young adults. The aim of this study was to detect the prevalence of antibody to hepatitis A virus in a population observed in our Travel Clinic.

Material And Methods: Antibodies against hepatitis A, hepatitis B, hepatitis C and human immunodeficiency virus were tested using standard enzyme immunoassay in patients older than 18. The exclusion criteria were: prior vaccination for hepatitis A virus, previous diagnosis of infection with hepatitis B virus, hepatitis C virus and/or human immunodeficiency virus, foreign travelers and long-term expatriates. We applied an epidemiological survey and data was statistically analyzed with SPSS® 18.0.

Results: In the 665 travelers studied, natural immunity to hepatitis A virus was present in 57.6% (n = 383). They were stratified into 8 age groups and for each one hepatitis A immunity was clarified: 5.0% (n = 1) in 18 - 25 years, 32.3% (n = 21) in 26 - 30 years, 40.9% (n = 47) in 31 - 35 years, 45.8% (n = 54) in 36 - 40 years, 68.7% (n = 79) in 41 - 45 years, 70.1% (n = 68) in 46 - 50 years, 80.8% (n = 63) in 51 - 55 years and 87.7% (n = 50) over 56 years old. In those who accepted further screening, positivity for hepatitis B core antibody was found in 0.6% (n = 3) travelers, hepatitis C virus infection in 1.1% (n = 6) and human immunodeficiency virus infection in 0.5% (n = 3) whose previous status was unknown. The most frequent travel destination was sub-Saharan Africa (72.6%; n = 483).

Discussion: We found 49.1% (n = 260) travelers under 50 years old susceptible to hepatitis A virus infection and for those between 40 and 50 years, 30.7% (n = 65) still need vaccine protection.

Conclusion: Across age groups there is a trend towards lower prevalence of hepatitis A virus antibody, in particular among youngsters, when compared with older Portuguese studies.

Download full-text PDF

Source
August 2017
6 Reads

Publication Analysis

Top Keywords

hepatitis virus
40
virus infection
16
hepatitis
14
virus
13
immunodeficiency virus
12
human immunodeficiency
12
prevalence hepatitis
12
years
10
hepatitis hepatitis
8
virus antibody
8
age groups
8
travelers
5
infection
5
clarified 50%
4
409% years
4
years 323%
4
years 458%
4
50% years
4
323% years
4
years 409%
4

Similar Publications

Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation.

J Travel Med 2009 Sep-Oct;16(5):344-8

Preventive Medicine and Epidemiology Department, Hospital Clinic/IDIBAPS, Barcelona, Spain.

Background: In recent years, the number of travelers aged >40 years who acquire hepatitis A while traveling has increased. Therefore, there is a need to review hepatitis A vaccination protocols in travelers. The aims of the study were to assess immunity levels to hepatitis A virus (HAV) in international travelers >40 years and to determine the least costly immunization strategy. Read More

View Article
January 2010

[Hepatitis A virus prevalence: Portuguese first results of low endemicity].

Acta Med Port 2004 May-Jun;17(3):219-24. Epub 2004 Jun 30.

Serviço de Pediatria, Hospital de São Marcos, Braga.

The prevalence of the hepatitis A virus in a population determines the degree of morbidity associated with this illness, that is, the higher the morbidity, the lower the prevalence. This study aims to obtain the prevalence of total antibody to the hepatitis A virus in children, 5 and 8 years of age, and in adolescents, 14 years of age. The study was based on two samples: the serum of 64 healthy five-year-olds and 76 healthy eight-year-olds living in the proximity of the São Marcos Hospital in Braga and the serum of 311 adolescents, aged 14, from a total population of 536 adolescents attending schools in Braga, North of Portugal. Read More

View Article
March 2006

Immunity to hepatitis A and hepatitis B in Indian and Chinese immigrants seen in a travel clinic in Massachusetts, United States.

J Travel Med 2006 Jul-Aug;13(4):212-8

Tufts University School of Medicine, Department of Medicine, Boston, MA, USA.

Immigrants to the United States from developing countries have a higher probability of previous infection with hepatitis A virus (HAV) and/or hepatitis B virus in their countries of origin. Prior knowledge of hepatitis A and B seroprevalence in this population may aid in determining the need for pretravel immunizations when these individuals travel to endemic regions. We conducted a retrospective analysis of hepatitis A and B serologies in a travel clinic population (from March 1999 through September 2002) to determine the seroprevalence in our predominantly highly educated foreign-born subjects. Read More

View Article
November 2006

Hepatitis B screening in travelers: a retrospective analysis.

Travel Med Infect Dis 2014 Nov-Dec;12(6 Pt B):707-12. Epub 2014 Jul 17.

Institut Pasteur, Centre Médical, 209 rue de Vaugirard, 75015 Paris, France. Electronic address:

Background: Non-immune travelers are at risk of acquiring hepatitis B (HB) in high prevalence countries.

Method: At the Institut Pasteur Vaccination Center in a retrospective study we retrieved hepatitis B serological data from the vaccination database between 2008 and 2012. Serology (HBsAg, HBsAb and HBcAb) is proposed to travelers who have no information about their previous HB vaccination status if they travel to countries of high or intermediate prevalence of HB, for long or frequent trips. Read More

View Article
September 2015